Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Glucotrack, Inc. (GCTK)
:GCTK
Holding GCTK?
Track your performance easily
GCTK Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.06 - $4.95
Previous Close$0.14
Volume195.77M
Average Volume (3M)62.36M
Market Cap
$1.18M
Enterprise ValueN/A
Total Cash (Recent Filing)$148.84K
Total Debt (Recent Filing)$162.03K
Price to Earnings (P/E)―
Beta0.44
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.89
Shares Outstanding16,052,172
10 Day Avg. Volume185,316,880
30 Day Avg. Volume62,362,422
Standard Deviation0.34
R-Squared0.00050
Alpha-0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
GlucoTrack News
PremiumCompany Announcements
GlucoTrack to Present at TechBio Showcase 2025
PremiumCompany Announcements
GlucoTrack Begins Clinical Study of Implantable Glucose Monitor
PremiumCompany Announcements
GlucoTrack Completes Funding to Enhance Financial Stability
PremiumCompany Announcements
GlucoTrack to Unveil Implantable Glucose Monitor at BioFuture
PremiumCompany Announcements
GlucoTrack Showcases Innovations at Diabetes Tech MeetingOwnership Overview
5.86% Insiders
―
Mutual Funds
0.09% Other Institutional Investors
94.05% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
GCTK FAQ
What was Glucotrack, Inc.’s price range in the past 12 months?
Glucotrack, Inc. lowest stock price was $0.06 and its highest was $4.95 in the past 12 months.
What is Glucotrack, Inc.’s market cap?
Glucotrack, Inc.’s market cap is $1.18M.
When is Glucotrack, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Glucotrack, Inc.’s earnings last quarter?
Glucotrack, Inc. released its earnings results on May 15, 2018. The company reported -$4.363 earnings per share for the quarter, missing the consensus estimate of N/A by -$4.363.
Is Glucotrack, Inc. overvalued?
According to Wall Street analysts Glucotrack, Inc.’s price is currently Overvalued.
Does Glucotrack, Inc. pay dividends?
Glucotrack, Inc. does not currently pay dividends.
What is Glucotrack, Inc.’s EPS estimate?
Glucotrack, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Glucotrack, Inc. have?
Glucotrack, Inc. has 16,052,172 shares outstanding.
What happened to Glucotrack, Inc.’s price movement after its last earnings report?
Glucotrack, Inc. reported an EPS of -$4.363 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Glucotrack, Inc.?
Currently, no hedge funds are holding shares in GCTK
---
Company Description
Glucotrack, Inc.
Integrity Applications, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Ashkelon, Israel.
---
Technical Analysis
Senseonics Holdings
―
Tandem Diabetes Care
―
Dexcom
―
Medtronic
―
Insulet
―
Abbott Laboratories
―
---